You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Drugs Containing Excipient (Inactive Ingredient) N-ACETYL-DL-TRYPTOPHAN


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing N-ACETYL-DL-TRYPTOPHAN excipient

N-ACETYL-DL-TRYPTOPHAN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for N-Acetyl-DL-Tryptophan

Introduction to N-Acetyl-DL-Tryptophan

N-Acetyl-DL-Tryptophan is a derivative of the amino acid tryptophan, widely used as a pharmaceutical excipient. It is characterized by its CAS number 87-32-1 and is known for its specific chemical and physical properties, such as a white to almost white appearance, a molar mass of 246.27 g/mol, and a melting point of 208.6 °C[2].

Market Size and Growth

The global N-Acetyl-DL-Tryptophan market has been experiencing significant growth. As of 2023, the market size was valued at approximately USD 88 million[1].

  • By 2030, the market is forecasted to reach a readjusted size of USD 139.1 million, growing at a Compound Annual Growth Rate (CAGR)[1].

For a longer-term perspective, the market is projected to reach USD 157.48 million by 2032, with a CAGR of 7.1% from 2024 to 2032[5].

Key Drivers of Market Growth

Increasing Demand in Pharmaceutical Industry

The pharmaceutical industry's growing need for high-quality excipients is a major driver. N-Acetyl-DL-Tryptophan is used in various pharmaceutical formulations due to its stability and compatibility with other ingredients.

Advancements in Healthcare and Technology

Advancements in healthcare and technology, particularly in drug research and development, are driving the demand for specialized excipients like N-Acetyl-DL-Tryptophan. The increasing focus on new drug R&D and the use of real-world data in Europe, for example, opens up new opportunities for the development of drugs and medicines[4].

Regulatory Compliance

Pharmaceutical companies must adhere to stringent regulatory standards, and N-Acetyl-DL-Tryptophan meets the requirements of various pharmacopeias such as Ph Eur and BP, making it a preferred choice[2].

Regional Market Analysis

Global Market Distribution

The global market for N-Acetyl-DL-Tryptophan is distributed across various regions, each with its own growth trajectory.

  • North America: This region is expected to contribute significantly to the market growth due to its large pharmaceutical industry and high demand for excipients.
  • Europe: Europe is another key region, with a growing focus on new drug R&D and an increasing trend towards digitization and use of real-world data, which is expected to drive the market[4].
  • Asia Pacific: The Asia Pacific region is also anticipated to grow at a significant CAGR, driven by the expanding pharmaceutical sector and increasing investment in healthcare infrastructure.

Market Segmentation

By Application

N-Acetyl-DL-Tryptophan is used in various pharmaceutical applications, including:

  • Tablets and Capsules: As a filler or binder to enhance the stability and efficacy of the final product.
  • Injectables: To improve the solubility and stability of injectable formulations.
  • Topical Preparations: In creams, ointments, and other topical formulations.

By Functionality

The functionality of N-Acetyl-DL-Tryptophan as a binder, filler, or stabilizer in pharmaceutical formulations is crucial. Its ability to enhance the physical and chemical properties of drugs makes it a versatile excipient[4].

Competitive Landscape

The market for N-Acetyl-DL-Tryptophan is competitive, with several key players involved in its production and distribution. Companies like EMD Millipore provide high-quality N-Acetyl-DL-Tryptophan that meets international standards, ensuring a strong market presence[2].

Pricing and Availability

The pricing of N-Acetyl-DL-Tryptophan varies based on the quantity and packaging. It is available in different packaging options, including plastic bottles and drums, catering to various needs of pharmaceutical manufacturers[2].

Safety and Regulatory Considerations

N-Acetyl-DL-Tryptophan must comply with strict safety and regulatory standards. The material safety data sheet (MSDS) and certificates of analysis are crucial documents that ensure the product meets the required safety and quality standards[2].

Future Outlook

The future of the N-Acetyl-DL-Tryptophan market looks promising, driven by the increasing demand for pharmaceutical excipients and advancements in healthcare technology. Here are some key points to consider:

  • Growing Pharmaceutical Industry: The global pharmaceutical industry is expected to grow significantly, driving the demand for high-quality excipients like N-Acetyl-DL-Tryptophan.
  • Technological Advancements: Continued advancements in drug R&D and the use of real-world data will further increase the demand for specialized excipients.
  • Regulatory Compliance: Adherence to regulatory standards will remain a critical factor in the market growth.

Key Takeaways

  • The global N-Acetyl-DL-Tryptophan market is projected to grow significantly, reaching USD 139.1 million by 2030 and USD 157.48 million by 2032.
  • The market is driven by increasing demand in the pharmaceutical industry, advancements in healthcare and technology, and regulatory compliance.
  • Regional markets such as North America, Europe, and Asia Pacific are expected to contribute significantly to the market growth.
  • N-Acetyl-DL-Tryptophan is used in various pharmaceutical applications, including tablets, capsules, injectables, and topical preparations.

FAQs

What is N-Acetyl-DL-Tryptophan used for in the pharmaceutical industry?

N-Acetyl-DL-Tryptophan is used as a pharmaceutical excipient to enhance the stability, solubility, and efficacy of various drug formulations.

What is the projected market size of N-Acetyl-DL-Tryptophan by 2030?

The global N-Acetyl-DL-Tryptophan market is forecasted to reach a readjusted size of USD 139.1 million by 2030[1].

Which regions are expected to drive the growth of the N-Acetyl-DL-Tryptophan market?

North America, Europe, and the Asia Pacific region are expected to drive the growth of the N-Acetyl-DL-Tryptophan market due to their large pharmaceutical industries and increasing focus on new drug R&D[4].

What are the key drivers of the N-Acetyl-DL-Tryptophan market growth?

The key drivers include increasing demand in the pharmaceutical industry, advancements in healthcare and technology, and regulatory compliance.

What is the CAGR of the N-Acetyl-DL-Tryptophan market from 2024 to 2032?

The N-Acetyl-DL-Tryptophan market is projected to grow at a CAGR of 7.1% from 2024 to 2032[5].

Sources

  1. News Channel Nebraska: N-Acetyl-DL-Tryptophan Market Analysis 2024: Key Dynamics, Top ...
  2. EMD Millipore: N-Acetyl-DL-tryptophan CAS 87-32-1 | 112488
  3. Panhandle News Channel Nebraska: 2024 N-Acetyl-DL-Tryptophan Market Analysis by Growth Up to 2032
  4. BioSpace: Pharmaceutical Excipients Market Size to Surge to US$ 14.72 Billion by 2033
  5. Global Growth Insights: N-Acetyl-DL-Tryptophan Market Size, Share, Trend, Growth [2024 ...

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.